Show simple item record

dc.contributor.authorCroft, J
dc.contributor.authorRiddell, A
dc.contributor.authorKoh, D-M
dc.contributor.authorDowney, K
dc.contributor.authorBlackledge, M
dc.contributor.authorUsher, M
dc.contributor.authorBoyd, K
dc.contributor.authorKaiser, M
dc.contributor.authorMessiou, C
dc.date.accessioned2020-08-12T11:24:09Z
dc.date.issued2020-07-14
dc.identifier.citationCancer imaging : the official publication of the International Cancer Imaging Society, 2020, 20 (1), pp. 48 - ?
dc.identifier.issn1740-5025
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3935
dc.identifier.eissn1470-7330
dc.identifier.doi10.1186/s40644-020-00328-9
dc.description.abstractBACKGROUND: Whole body magnetic resonance imaging (MRI) is now incorporated into international guidance for imaging patients with multiple myeloma. The aim of this study was to investigate inter-observer agreement of triple reported baseline whole-body MRI in myeloma and highlight potential pitfalls. METHODS: Fifty-seven patients with symptomatic myeloma at first presentation or relapse and planned for autologous stem cell transplant were included. All patients completed baseline whole body MRI within 2 weeks prior to starting treatment. Each scan was reported independently by 3 radiologists using a defined scoring system. Differences in observer scores were compared using analysis of variance (ANOVA) and inter-observer agreement assessed using intra class correlation coefficient (ICC). RESULTS: There was no significant difference in mean observer scores for whole skeleton and ICC demonstrated excellent inter-observer agreement at 0.91. ICC varied between skeletal regions with spine, pelvis and ribs showing good inter-observer agreement, whereas skull and long bones were moderate. Scans with variation in observer scores were re-examined and cause of discrepancies identified. This information was used to describe potential anatomical pitfalls in reporting . CONCLUSION: Whole-body MRI has excellent inter-observer agreement in reporting symptomatic myeloma at baseline. Inter-observer agreement varied between skeletal regions highlighting specific areas of difficulty.
dc.formatElectronic
dc.format.extent48 - ?
dc.languageeng
dc.language.isoeng
dc.publisherBMC
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectMultiple Myeloma
dc.subjectObserver Variation
dc.subjectMagnetic Resonance Imaging
dc.subjectReproducibility of Results
dc.subjectMiddle Aged
dc.subjectFemale
dc.subjectMale
dc.subjectWhole Body Imaging
dc.titleInter-observer agreement of baseline whole body MRI in multiple myeloma.
dc.typeJournal Article
dcterms.dateAccepted2020-07-08
rioxxterms.versionofrecord10.1186/s40644-020-00328-9
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2020-07-14
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfCancer imaging : the official publication of the International Cancer Imaging Society
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Computational Imaging
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Computational Imaging
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume20
pubs.embargo.termsNot known
icr.researchteamMyeloma Group
icr.researchteamComputational Imaging
dc.contributor.icrauthorCroft, James
dc.contributor.icrauthorBlackledge, Matthew
dc.contributor.icrauthorKaiser, Martin


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0